Despite their clinical differences, these disorders share key pathological hallmarks, such as the accumulation and aggregation of disease-specific proteins, for example tau (MAPT) in AD and other tauopathies and α-synuclein (SNCA) in PD and other synucleinopathies [19,20]. This evidence concerns the gene SNCA and synucleinopathy.